期刊文献+

测定K562/G01细胞内伊马替尼浓度及甲基莲心碱对其转运的影响

Determination of imatinib concentration in K562/G01 cells and effect of neferine on imatinib transportion
下载PDF
导出
摘要 目的建立测定K562/G01细胞株(imatinib-resistant K562 cells,耐伊马替尼K562细胞株)内伊马替尼浓度的方法,探讨甲基莲心碱对其细胞内STI571转运的影响。方法采用反相高效液相色谱法(reversedphase high-performance liquid chromatographic,RP-HPLC)直接测定药物浓度。色谱柱为:Gemini C18(250 mm×4.6 mm,5μm);流动相为:0.02 mol L-1KH2PO4-CH3CN=65:35;流速:1.0 mL min-1;检测波长:265 nm。结果采用外标法以峰面积定量,以色谱峰面积对STI571浓度进行线性回归,得回归方程:A=83.08C-7.975,r=0.999 4。线性范围49.51~3 076.92 ng mL-1,相对回收率分别>95%,日内日间RSD均<10%。结论该方法准确、快速、操作简便,可用于细胞内药物浓度的测定与研究。结果显示甲基莲心碱能影响细胞内STI571的转运。 Objective To develop an RP-HPLC method to detemine the imatinib concentration in K562/G01 cells(imatinib-resistant K562 cells),and to determine the effect of neferine on STI571 transportion.Methods RP-HPLC was used to determine the concentration of STI571.Assay was conducted using a Gemini C18(250 mm×4.6 mm,5 μm) with mobile phase consisting of 0.02 mol · L-1 potassium dihydrogen phosphate and acetonitrile(65 : 35) at a ·ow rate of 1.0 mL · min-1 and detected at 265 nm.Results Linear regression was made on the concentration of STI571 with peak area quantitate and chromatographic peak area the external reference method,the regression equation: A= 83.08C-7.975,r = 0.999 4.The relative recoveries were95%,the inter-and intra-day RSD was10%.Calibration plots in K562/G01 cells were linear at 49.51-3 076.92 ng · mL-1.Conclusion This method is accurate,quick and simple,which can be used for the determination of the intracellular concentrations of drugs.Neferine can affect the transportation of STI571.
出处 《中南药学》 CAS 2012年第10期741-744,共4页 Central South Pharmacy
基金 湖南省自然科学基金(编号:08JJ5011)
关键词 伊马替尼 K562细胞 高效液相色谱法 imatinib K562 cell RP-HPLC
  • 相关文献

参考文献12

  • 1Hughes T,Deininger M,Hochhaus A,et al.Monitoring CML patients responding to treatment with tyrosine kinase in-hibitors:review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results[J].Blood,2006,108(1):28-37.
  • 2Goldman JM.How I treat chronic myeloid leukemia in the imati-nib era[J].Blood,2007,110(8):2828-2837.
  • 3Julia Thomas,Lihui Wang,Richard E,et al.Active transport of imatinib into and out of cells:implicationsfor drug resistance[J].Blood,2004,104(12):3739-3745.
  • 4Nicolas Widmer,Sara Colombo,Thierry Buclin,et al.Func-tional consequence of MDR1expression on imatinib intracellu-lar concentrations[J].Blood,2003,102(3):1142.
  • 5Illmer T,Schaich M,Platzbecker U,et al.P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic mye-logenous leukemia cells to treatment with imatinib mesylate[J].Leukemia,2004,18(3):401-408.
  • 6Schleyer E,Pursche S,K hne CH,et al.Liquid chromato-graphic method for detection and quantitation of STI-571and its main metabolite N-desmethyl-STI in plasma,urine,cerebro-spinal fluid,culture medium and cell preparations[J].Journal of Chromatography B,2004,799(1):23-36.
  • 7Hegedus C,zvegy-Laczka C,Apátiá,et al.Interaction of nilotinib,dasatinib and bosutinib with ABCB1and ABCG2:implications for altered anti-cancer effects and pharmacological properties[J].British Journal of Pharmacology,2009,158(4):1153-1164.
  • 8Guetens G,Prenen H,De Boeck G,et al.Simultaneous deter-mination of AMN107and Imatinib(Gleevec,Glivec,STI571)in cultured tumour cells using an isocratic high-performance liquid chromatography procedure with UV detection[J].Journal of Chromatography B,2007,846(1-2):341-345.
  • 9Olivia Roth,Odile Spreux-Varoquaux,Stephane Bouchet,et al.Imatinib assay by HPLC with photodiode-array UV detection in plasma from patients with chronic myeloid leukemia:Com-parison with LC-MS/MS[J].Clinica Chimica Acta,2010,411(3-4):140-146.
  • 10Yusa K,Tsumo T.Reversal mechanism of multidrug resis-tance by vempamil:direet binding of verapamil to P-gP on spe-cificsites and transport of verapamil outward across the plasma membrane of K562/ADM cells[J].Cancer Res,1989,49(18):5002-5006.

二级参考文献4

  • 1郭毛娣,中草药,1984年,15卷,7期,291页
  • 2团体著者,中药大辞典,1975年
  • 3潘竞先,北京医科大学学报,1987年,19卷,3期,177页
  • 4夏国瑾,同济医科大学学报,1986年,15卷,200页

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部